These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 22890582)
1. Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study. Ichikawa K; Okabayashi T; Maeda H; Namikawa T; Iiyama T; Sugimoto T; Kobayashi M; Mimura T; Hanazaki K Surg Today; 2013 Jul; 43(7):720-6. PubMed ID: 22890582 [TBL] [Abstract][Full Text] [Related]
2. Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Okabayashi T; Iyoki M; Sugimoto T; Kobayashi M; Hanazaki K Amino Acids; 2011 Apr; 40(4):1213-20. PubMed ID: 20852905 [TBL] [Abstract][Full Text] [Related]
3. Effects of branched-chain amino acids on postoperative tumor recurrence in patients undergoing curative resection for hepatocellular carcinoma: A randomized clinical trial. Hachiya H; Aoki T; Iso Y; Shimizu T; Tago K; Park KH; Sakuraoka Y; Shiraki T; Mori S; Kubota K J Hepatobiliary Pancreat Sci; 2020 Nov; 27(11):819-829. PubMed ID: 32949091 [TBL] [Abstract][Full Text] [Related]
4. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial. Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546 [TBL] [Abstract][Full Text] [Related]
5. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery. Br J Surg; 1997 Nov; 84(11):1525-31. PubMed ID: 9393270 [TBL] [Abstract][Full Text] [Related]
6. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation. Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049 [TBL] [Abstract][Full Text] [Related]
7. Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Meng WC; Leung KL; Ho RL; Leung TW; Lau WY Aust N Z J Surg; 1999 Nov; 69(11):811-5. PubMed ID: 10553972 [TBL] [Abstract][Full Text] [Related]
8. Prospective randomized controlled study of short-term perioperative oral nutrition with branched chain amino acids in patients undergoing liver surgery. Ishikawa Y; Yoshida H; Mamada Y; Taniai N; Matsumoto S; Bando K; Mizuguchi Y; Kakinuma D; Kanda T; Tajiri T Hepatogastroenterology; 2010; 57(99-100):583-90. PubMed ID: 20698232 [TBL] [Abstract][Full Text] [Related]
9. [Effect of oral administration of branched-chain amino acids supplementation on the mortality of patients with hepatocellular carcinoma: a meta-analysis]. Xue WX; Yang F; Duan JJ; Sun JB; Peng H Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3793-3800. PubMed ID: 33379845 [No Abstract] [Full Text] [Related]
10. A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma. Kikuchi Y; Hiroshima Y; Matsuo K; Kawaguchi D; Murakami T; Yabushita Y; Endo I; Taguri M; Koda K; Tanaka K Ann Surg Oncol; 2016 Oct; 23(11):3727-3735. PubMed ID: 27338747 [TBL] [Abstract][Full Text] [Related]
11. The benefit of the supplementation of perioperative branched-chain amino acids in patients with surgical management for hepatocellular carcinoma: a preliminary study. Okabayashi T; Nishimori I; Sugimoto T; Iwasaki S; Akisawa N; Maeda H; Ito S; Onishi S; Ogawa Y; Kobayashi M; Hanazaki K Dig Dis Sci; 2008 Jan; 53(1):204-9. PubMed ID: 17510798 [TBL] [Abstract][Full Text] [Related]
12. Supplementation of branched-chain amino acids maintains the serum albumin level in the course of hepatocellular carcinoma recurrence. Kakazu E; Kondo Y; Kogure T; Ninomiya M; Kimura O; Iwata T; Morosawa T; Iwasaki T; Shimosegawa T Tohoku J Exp Med; 2013 Aug; 230(4):191-6. PubMed ID: 23892757 [TBL] [Abstract][Full Text] [Related]
13. Branched-chain amino acid granules improve the non-protein respiratory quotient after radiofrequency ablation. Saito M; Yano Y; Minami A; Hirano H; Momose K; Sugimoto M; Yoshida M; Azuma T Intern Med; 2014; 53(14):1469-75. PubMed ID: 25030556 [TBL] [Abstract][Full Text] [Related]
14. Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma. Okabayashi T; Nishimori I; Sugimoto T; Maeda H; Dabanaka K; Onishi S; Kobayashi M; Hanazaki K J Gastroenterol Hepatol; 2008 Dec; 23(12):1869-73. PubMed ID: 18717761 [TBL] [Abstract][Full Text] [Related]
15. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis. Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025 [TBL] [Abstract][Full Text] [Related]
16. Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial. Beppu T; Nitta H; Hayashi H; Imai K; Okabe H; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Yoshida M; Yamashita Y; Baba H J Gastroenterol; 2015 Dec; 50(12):1197-205. PubMed ID: 25847401 [TBL] [Abstract][Full Text] [Related]
17. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial. Ishizuka M; Kubota K; Nemoto T; Shimoda M; Kato M; Iso Y; Tago K Asian J Surg; 2016 Jul; 39(3):149-54. PubMed ID: 26123137 [TBL] [Abstract][Full Text] [Related]
18. Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial. Yoshiji H; Noguchi R; Ikenaka Y; Kaji K; Aihara Y; Yamazaki M; Yamao J; Toyohara M; Mitoro A; Sawai M; Yoshida M; Morioka C; Fujimoto M; Uemura M; Fukui H Oncol Rep; 2011 Dec; 26(6):1547-53. PubMed ID: 21874260 [TBL] [Abstract][Full Text] [Related]
19. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. Ziegler TR JPEN J Parenter Enteral Nutr; 1996; 20(1):91-2. PubMed ID: 8788271 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma. Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Kakisaka T; Tsuruga Y; Todo S; Taketomi A World J Surg Oncol; 2012 Jun; 10():107. PubMed ID: 22697061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]